​

Nexalin Technology, Inc.

NasdaqCM:NXL Stock Report

Market Cap: US$19.0m

Nexalin Technology (NXL) Stock Overview

A medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. More details

NXL fundamental analysis
Snowflake Score
Valuation1/6
Future Growth2/6
Past Performance0/6
Financial Health6/6
Dividends0/6

Rewards

Revenue is forecast to grow 118.82% per year

Risk Analysis

Makes less than USD$1m in revenue ($131K)

Shareholders have been substantially diluted in the past year

Earnings are forecast to decline by an average of 7.4% per year for the next 3 years

Currently unprofitable and not forecast to become profitable over the next 3 years

+ 2 more risks

NXL Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

Nexalin Technology, Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Nexalin Technology
Historical stock prices
Current Share PriceUS$1.09
52 Week HighUS$4.49
52 Week LowUS$0.59
Beta3.75
1 Month Change4.81%
3 Month Change-37.14%
1 Year Change-12.10%
3 Year Changen/a
5 Year Changen/a
Change since IPO-51.56%

Recent News & Updates

Recent updates

Will Nexalin Technology (NASDAQ:NXL) Spend Its Cash Wisely?

Mar 14
Will Nexalin Technology (NASDAQ:NXL) Spend Its Cash Wisely?

Nexalin Technology (NASDAQ:NXL) Is In A Good Position To Deliver On Growth Plans

Nov 29
Nexalin Technology (NASDAQ:NXL) Is In A Good Position To Deliver On Growth Plans

Shareholder Returns

NXLUS Medical EquipmentUS Market
7D9.5%-1.6%0.9%
1Y-12.1%5.6%14.8%

Return vs Industry: NXL underperformed the US Medical Equipment industry which returned 5.5% over the past year.

Return vs Market: NXL underperformed the US Market which returned 15% over the past year.

Price Volatility

Is NXL's price volatile compared to industry and market?
NXL volatility
NXL Average Weekly Movement10.8%
Medical Equipment Industry Average Movement8.1%
Market Average Movement6.4%
10% most volatile stocks in US Market16.9%
10% least volatile stocks in US Market3.1%

Stable Share Price: NXL's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: NXL's weekly volatility has decreased from 18% to 11% over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
n/a6Mark Whitewww.nexalin.com

Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company offers Generation 1, an easy-to-administer medical device which utilizes bioelectronic medical technology to treat anxiety, insomnia, and depression without the need for drugs or psychotherapy; and Generation 2 and Generation 3 headset devices for the treatment of depression, substance use disorder, traumatic brain injury, post-traumatic stress disorder, opioid addiction, alcoholism, and chronic pain, as well as alzheimer’s disease, and dementia. Nexalin Technology, Inc. is headquartered in Houston, Texas.

Nexalin Technology, Inc. Fundamentals Summary

How do Nexalin Technology's earnings and revenue compare to its market cap?
NXL fundamental statistics
Market capUS$18.99m
Earnings (TTM)-US$8.55m
Revenue (TTM)US$131.07k
144.9x
P/S Ratio
-2.2x
P/E Ratio

Is NXL overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
NXL income statement (TTM)
RevenueUS$131.07k
Cost of RevenueUS$41.00k
Gross ProfitUS$90.07k
Other ExpensesUS$8.64m
Earnings-US$8.55m

Last Reported Earnings

Mar 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)-0.49
Gross Margin68.72%
Net Profit Margin-6,526.81%
Debt/Equity Ratio0%

How did NXL perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/07/20 22:23
End of Day Share Price 2025/07/18 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Nexalin Technology, Inc. is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Sinclair CurrieMA Moelis Australia Securities Pty Ltd
Anthony VendettiMaxim Group